MedPath

FeRiva 21-7 28-Day

FeRiva 21/7Rx OnlyDietary Supplement

Approved
Approval ID

5f2ad0e5-13dc-4959-9b6c-d696b7145063

Product Type

DIETARY SUPPLEMENT

Effective Date

Apr 18, 2025

Manufacturers
FDA

Trifluent Pharma, LLC

DUNS: 117167281

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acids and succinic acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code73352-318
Product Classification
G
Generic Name
ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acids and succinic acid
Product Specifications
Route of AdministrationORAL
Effective DateApril 18, 2025
FDA Product Classification

INGREDIENTS (16)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
ASCORBIC ACIDActive
Quantity: 175 mg in 1 1
Code: PQ6CK8PD0R
Classification: ACTIB
ZINC GLYCINATEActive
Quantity: 10 mg in 1 1
Code: 681VJX72FE
Classification: ACTIB
CYANOCOBALAMINActive
Quantity: 12 ug in 1 1
Code: P6YC3EG204
Classification: ACTIB
FERROUS ASPARTO GLYCINATEActive
Quantity: 75 mg in 1 1
Code: H7426RGB3L
Classification: ACTIM
SUCCINIC ACIDActive
Quantity: 50 mg in 1 1
Code: AB6MNQ6J6L
Classification: ACTIB
DICALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
FOLIC ACIDActive
Quantity: 1667 ug in 1 1
Code: 935E97BOY8
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/18/2025

STATEMENT OF IDENTITY SECTION

LOINC: 69718-5Updated: 4/18/2025

WARNINGS SECTION

LOINC: 34071-1Updated: 4/18/2025

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 4/18/2025

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 4/18/2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FeRiva 21-7 28-Day - FDA Drug Approval Details